$42.99
-0.02-0.05%
近くで: Nov 16, 4:00 PM EST
$42.99
N/A
時間外: 4:00 PM EST

LB Pharmaceuticals (LBRX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $-1.79 | $-1.60 | -11.9 % |
| Q2 | Aug 11, 2026 | $-1.71 | $-0.81 | -111.1 % |
| Q1 | May 12, 2026 | $-0.67 | $-0.69 | 2.90 % |
| Q4 | Mar 26, 2026 | $-0.45 | $-0.37 | -21.6 % |
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.60 | $-0.81 | $-0.69 | $-0.37 |
| Actual | $-1.79 | $-1.71 | $-0.67 | $-0.45 |
| Surprise | -11.9% | -111.1% | +2.90% | -21.6% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.83 | $-1.77 | $-1.45 | $-1.30 |
| Revenue | ||||
| Consensus | — | — | — | — |